China Diabetes Care Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

China Diabetes Care Devices Market Overview

Diabetes care devices are experiencing steady technological progress, improving disease monitoring and treatment efficiency while supporting better patient engagement. The integration of digital health solutions continues to enhance diabetes management. The market is poised to reach USD 27.05 Billion by 2035. The market is expanding due to the rising diabetic population, healthcare modernization, increased domestic manufacturing, and greater adoption of innovative glucose monitoring and insulin delivery systems.

China Diabetes Care Devices Market Growth Analysis and Key Influencers

China Diabetes Care Devices Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

China Diabetes Care Devices Market Growth Drivers

Advancements in Wearable Diabetes Monitoring Technologies Accelerating the Market Value

Continuous innovation in wearable diabetes care technologies is strengthening the market by enabling more accurate, convenient, and personalized glucose management. According to Sun Yat-sen University, in July 2025, researchers from Sun Yat-sen University and the Technion–Israel Institute of Technology developed a painless wearable microneedle device that continuously monitors glucose and metformin levels while providing real-time treatment guidance through a smartphone application. Technology has the potential to improve diabetes management and reduce complications, supporting continued innovation and long-term expansion of the market.

China Diabetes Care Devices Market Restraints

High Cost of Advanced Diabetes Care Devices Limits the Market Expansion

The high cost of advanced diabetes care devices, including continuous glucose monitoring devices and insulin delivery technologies, continues to limit wider adoption, particularly among uninsured or underinsured patients. Expensive devices, recurring sensor replacement costs, and affordability concerns create barriers to consistent diabetes management. For example, in July 2026, STAT reported ongoing supply challenges involving Sanofi insulin pens, highlighting vulnerabilities in diabetes care availability. Such cost and supply-related issues may continue to restrain the market's overall growth.

China Diabetes Care Devices Market Opportunities

Growing Development of Integrated Diabetes Management Solutions Expands the Market Potential

The increasing focus on integrated diabetes management technologies is creating substantial opportunities for the market by improving treatment convenience and patient adherence. For example, in June 2025, PharmaSens and SiBionics announced a strategic collaboration to develop an all-in-one wearable insulin patch pump combining continuous glucose monitoring with real-time insulin delivery. This next-generation solution is designed to simplify diabetes management and reduce the daily treatment burden, supporting future innovation and expanding the market's long-term potential.

China Diabetes Care Devices Market Trends

The market is witnessing several trends, including wearable continuous glucose monitoring, integrated insulin delivery systems, and remote patient monitoring.

Rising Adoption of Advanced Continuous Glucose Monitoring Technologies is Expected to Boost the Market Growth

The increasing adoption of advanced continuous glucose monitoring systems is emerging as a prominent trend, driven by demand for convenient, real-time diabetes management. For example, in November 2023, Sibionics received CE Mark approval for its GS1 continuous glucose monitoring system, offering 14-day glucose monitoring, smartphone connectivity, remote data sharing, and reduced calibration requirements. Such advancements are expected to encourage wider adoption of wearable diabetes technologies and strengthen the market's future growth.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

China Diabetes Care Devices Market Share

Type 2 Diabetes is Expected to Lead the Market Share by Disease Type

The market is segmented by disease type into type 1 diabetes and type 2 diabetes. Among these, type 2 diabetes is expected to dominate due to its substantially higher patient population, increasing prevalence, and growing demand for continuous glucose monitoring and insulin delivery devices. For example, in June 2026, Adocia presented Phase 3 clinical results for BioChaperone® Lispro in patients with Type 2 diabetes at the American Diabetes Association Scientific Sessions, demonstrating improved glycemic control. Such advancements reinforce the demand for advanced diabetes care technologies and support the continued leadership of the type 2 diabetes segment.

Leading Players in the China Diabetes Care Devices Market

China Diabetes Care Devices Market Segmentation

Key Questions Answered in the China Diabetes Care Devices Market Report

• What was the China diabetes care devices market value in 2025?
• What is the China diabetes care devices market forecast outlook for 2026-2035?
• What are the major factors aiding the China diabetes care devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major diabetes care devices market trends?
• Which product type is expected to dominate the market segment?
• Which disease type is projected to lead the market segment?
• Which patient care setting is anticipated to drive the market segment?
• Who are the key players involved in the China diabetes care devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: In-depth interviews conducted with 30+ endocrinologists, diabetologists, diabetes educators, hospital procurement managers, medical device distributors, reimbursement specialists, and healthcare professionals across China, including key opinion leaders (KOLs) associated with the Chinese Diabetes Society, Chinese Medical Association, and leading tertiary hospitals and diabetes care institutions across the country.
• Secondary Research: Peer-reviewed publications from Diabetes Care, The Lancet Diabetes & Endocrinology, and the Journal of Diabetes Science and Technology; regulatory documents from the National Medical Products Administration (NMPA); epidemiological data from the National Health Commission of the People's Republic of China (NHC), Chinese Center for Disease Control and Prevention (China CDC), the IDF Diabetes Atlas, and WHO; along with product portfolios, annual reports, investor presentations, company filings, and press releases from leading diabetes care device manufacturers.
• Validation: All quantitative estimates are triangulated using top-down and bottom-up market modeling and validated through iterative expert feedback and cross-verification with industry stakeholders.